Pharmaceutical giant Bayer calls global ad and media review
By Matt Williams, campaignlive.co.uk, Friday, 17 July 2009 09:20AM
LONDON - Bayer AG, the German pharmaceutical and chemical giant, has called a global consolidation review of the advertising and media accounts for its healthcare division.
The company said that it has called the review in a bid to improve the effectiveness and efficiency of its creative and media buying operations.
It is not yet clear which companies will participate in the process, but it is thought to involve two of Bayer's global creative agencies, BBDO and JWT, as well as its largest media agencies, which are Initiative in the US and Mindshare in the UK.
All the agencies involved in the review have already held initial meetings with Bayer, but a formal response to the RFP that has been issued is not due until later this summer.
The review is expected to be completed by the end of the third quarter of this year.
This article was first published on campaignlive.co.uk
- Senior Planner Buyer Dot-Gap £35k, London (Central), London (Greater)
- Assistant Brand Manager Ball & Hoolahan £28,000 per annum, South East England
- Brand & Packaging Manager Ball & Hoolahan £36,000 + c/a, London (Central), London (Greater)
- Brand Manager Ball & Hoolahan £40,000 per annum, South West England
- Category Manager Ball & Hoolahan £50,000 per annum, South East England
- Google's European leader says viewing habits are 'changing dramatically'
- Tesco media review pits Initiative against MediaCom and ZenithOptimedia
- Martin Sorrell talks Maurice Lévy, Tesco, and the global outlook
- Land Rover to move global ad account into Spark44
- Viacom to bring Breaking Bad to Freeview with Spike launch
- 'Advertisers are snake oil salesmen', says Peter Oborne